Aura Biosciences, Inc. AURA Balance Sheet Statement
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| $59.52M+87.8% | $31.69M-22.8% | $41.06M-66.2% | $121.58M-18.4% | ||
| $768K— | $0-100% | $19K-5.0% | $20K-13.0% | ||
| $5.5M-42.3% | $9.53M+69.4% | $5.63M-28.5% | $7.87M+70.4% | ||
| $149.74M-6.8% | $160.62M-30.7% | $231.79M+17.8% | $196.7M+28.0% | ||
| $2.62M-18.4% | $3.22M+2.1% | $3.15M-41.4% | $5.37M+2.3% | ||
| $15.83M-8.9% | $17.38M-7.8% | $18.85M-8.8% | $20.67M+2,076% | ||
| $471K-9.1% | $518K+1.8% | $509K+20.3% | $423K— | ||
| $169.43M-7.2% | $182.5M-28.5% | $255.08M+13.9% | $223.94M+39.9% | ||
| $6.73M-12.5% | $7.69M+57.4% | $4.89M-37.4% | $7.8M+35.7% | ||
| $3.24M+3.0% | $3.15M+17.2% | $2.69M-9.3% | $2.96M+382% | ||
| $18.38M+23.3% | $14.91M+20.7% | $12.36M+18.2% | $10.46M+42.2% | ||
| $14.13M-9.5% | $15.62M-7.4% | $16.87M-5.7% | $17.9M+4,871% | ||
| $17.38M-7.4% | $18.77M-4.0% | $19.56M-6.2% | $20.86M+2,039% | ||
| $32.52M+6.5% | $30.53M+4.5% | $29.23M+3.1% | $28.35M+267% | ||
| $617.43M+17.4% | $525.93M+2.6% | $512.62M+26.1% | $406.56M+33.5% | ||
| -$480.42M-28.4% | -$374.23M-30.3% | -$287.31M-36.2% | -$210.9M-38.6% | ||
| -$102K-139% | $263K-51.2% | $539K+849% | -$72K— | ||
| $136.91M-9.9% | $151.97M-32.7% | $225.85M+15.5% | $195.58M+28.4% | ||
| $169.43M-7.2% | $182.5M-28.5% | $255.08M+13.9% | $223.94M+39.9% | ||
| $471K-9.1% | $518K+1.8% | $509K+20.3% | $423K— | ||
| $15.83M-8.9% | $17.38M-7.8% | $18.85M-8.8% | $20.67M+2,076% | ||
| $15.83M-8.9% | $17.38M-7.8% | $18.85M-8.8% | $20.67M+2,076% | ||
| $471K-9.1% | $518K+1.8% | $509K+20.3% | $423K— | ||
| $15.83M-8.9% | $17.38M-7.8% | $18.85M-8.8% | $20.67M+2,076% | ||
| $471K-9.1% | $518K+1.8% | $509K+20.3% | $423K— | ||
| $13.59M+43.7% | $9.46M+20.0% | $7.88M+72.4% | $4.57M+5.4% | ||
| $17.38M-7.4% | $18.77M-4.0% | $19.56M-6.2% | $20.86M+2,039% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Aura Biosciences, Inc.'s total assets?
- Aura Biosciences, Inc. (AURA) holds $137.7M in total assets, down 11.4% year over year.
- How much debt does Aura Biosciences, Inc. have?
- Aura Biosciences, Inc. carries $17.0M in total debt against $107.2M of shareholders' equity, a debt-to-equity ratio of 0.16.
- How much cash does Aura Biosciences, Inc. have?
- Aura Biosciences, Inc. holds $84.8M in cash and equivalents.
- Can Aura Biosciences, Inc. cover its short-term obligations?
- Its current ratio is 7.09 — current assets exceed current liabilities.
- Where does Aura Biosciences, Inc.'s balance sheet data come from?
- Every line is extracted from Aura Biosciences, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.